Robert W. Humble
University of Hull
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert W. Humble.
Journal of Carbohydrate Chemistry | 1991
David F. Ewing; Robert W. Humble; Grahame Mackenzie
ABSTRACT Configurational assignments for a series of N-acyl-D-ribofuranosylamines have been established unequivocally using a set of NMR criteria. The conformation of the exo-cyclic substituents is determined.
Journal of Carbohydrate Chemistry | 1993
David F. Ewing; Johann Hiebl; Robert W. Humble; Grahame Mackenzie; Anthony Raynor; Erich Zbiral
Abstract Efficient stereospecific N-formylation of ribosylamine has been achieved, affording the α-anomer directly (by reaction with formic-acetic anhydride) and the β-anomer via the corresponding formamidine derivative (by reaction with dimethylformamide dimethyl acetal). Dehydration of the α-anomer gave the corresponding isocyanide without compromising the anomeric purity. The amidine route was extended to give the N-formyl derivatives of α-xylosylamine and α-arabinosylamine.
Nucleosides, Nucleotides & Nucleic Acids | 1984
Robert W. Humble; Graham Mackenzie; Gordon Shaw
Abstract Several D-ribofuranosyl, D-xylofuranosyl and D-arabinofuranosyl 5-aminoimidazoles have been successfully phosphorylated to 5’ -phosphates using a phosphotransferase from wheat shoots and p-nitrophenylphosphate as a phosphate donor.
Nucleosides, Nucleotides & Nucleic Acids | 1995
David F. Ewing; Robert W. Humble; Grahame Mackenzie; Gordon Shaw
Abstract Mizoribine® (4-carbamoyl-1-β-D-ribofuranosylimidazolium-5-olate)(13β) and its 4-cyano analogue (20) were synthesized by formation of a malonamide from 2,3-isopropylidene-D-ribosylamine and a malonic acid derivative followed by amination, cyclisation and deprotection steps.
Nucleosides, Nucleotides & Nucleic Acids | 1989
Grahame Mackenzie; Hilary A. Wilson; Robert W. Humble; Fawzy Hewedi; Gordon Shaw; David F. Ewing
Abstract Routes to 2-alkylated-5-aminoimidazole nucleosides have been investigated in which the 2-substituent has up to 3 carbon atoms and capable of being interconverted into suitable oxy and 0x0 alkyl derivatives for use in enzyme inhibition and biochemical incorporation studies involving both purine nucleotide de novo and thiamine biosynthesis.
Nucleosides, Nucleotides & Nucleic Acids | 1989
David F. Ewing; Robert W. Humble; Antonin Holy; Grahame Mackenzie; Gordon Shaw; Ivan Votruba
Abstract In our studies aimed at the synthesis of inhibitors of enzymes involved in the de novo biosynthesis of purine nucleotides, the arabinosyl nucleoside (la), which is analogous to CAIR (lb), a central intermediate in the pathway, showed significant inhibition and substrate activities. We were therefore interested to synthesize the related 2-deoxy-D-ribosyl nucleotide (lc) for further enzymological studies.
Advances in Experimental Medicine and Biology | 1991
Robert W. Humble; Grahame Mackenzie; Gordon Shaw
Previously reported partial purification protocols for the enzymes EC 4.1.1.21 and EC 6.3.2.6 have proved either unsuccessful in resolving the enzyme activities1, or have only considered one of the enzymes2,4,5,6. These procedures involve numerous precipitation and lengthy chromatographic steps, with a subsequent loss in activity, especially of EC 6.3.2.6 which is highly labile. In addition, it is difficult to ascertain the purity of the enzymes obtained by the previous workers, due either to the abscence of, or only limited electrophoretic evidence reported.
Carbohydrate Research | 1992
David F. Ewing; Antonín Holý; Ivan Votruba; Robert W. Humble; Grahame Mackenzie; Fawzy Hewedi; Gordon Shaw
Tetrahedron Letters | 2011
Robert W. Humble; Danielle F. Middleton; Joseph H. Banoub; David F. Ewing; Andrew N. Boa; Grahame Mackenzie
Carbohydrate Research | 1991
David F. Ewing; Robert W. Humble; Grahame Mackenzie; Anthony Raynor; Gordon Shaw